Stock 600513 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Equities

600513

CNE000001DP6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-05-06 EDT 		5-day change 1st Jan Change
9.69 CNY 0.00% Intraday chart for Jiangsu Lianhuan Pharmaceutical Co., Ltd. +4.31% -13.02%
04-29 Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-09 Lianhuan Pharma Obtains China Registration Approval for Antihistamine MT

Business Summary

Jiangsu Lianhuan Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, production and sales of chemical medicines. The Company's products are mainly applied as urinary system medicines, antihistamines and cardiovascular medicines. The Company's products include Epristeride Tablets, Ebastine Tablets, Felodipine Tablets, Felodipine Sustained Release Capsules, Simvastatin Tablets, Lumbrokinase Capsulesand and Balofloxacin Tablets. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 1,296

Sales per Business

CNY in Million2022Weight2023Weight Delta
Tablet
49.6 %
1,080 55.3 % 1,078 49.6 % -0.25%
Medical Device
24.3 %
378 19.3 % 529 24.3 % +39.94%
API
12.7 %
230 11.7 % 276 12.7 % +20.33%
Other
8.0 %
150 7.7 % 175 8.0 % +16.52%
Injection
4.4 %
101 5.2 % 95 4.4 % -6.31%
Other Business
1.0 %
16 0.8 % 21 1.0 % +34.37%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.3 %
1,901 98.0 % 2,115 98.3 % +11.25%
International
1.7 %
38 2.0 % 37 1.7 % -1.21%

Managers

Managers TitleAgeSince
Ben Niu CEO
 Chief Executive Officer 43 20-05-21
Wen Ge Wu CHM
 Chairman 56 14-05-16
He Ping Pan DFI
 Director of Finance/CFO 60 09-06-18
Bao Chang Yu BRD
 Director/Board Member 40 12-01-31
Wen Tao Huang SEC
 Corporate Secretary 35 18-02-28

Members of the board

Members of the board TitleAgeSince
He Ping Pan DFI
 Director of Finance/CFO 60 09-06-18
Bin Zhang BRD
 Director/Board Member 56 20-05-21
Guang Ji Wang BRD
 Director/Board Member 71 18-08-21
Ying Chen BRD
 Director/Board Member 47 19-07-31
Wen Ge Wu CHM
 Chairman 56 14-05-16
Zhen Hua Qian CHM
 Chairman 53 -
Bao Chang Yu BRD
 Director/Board Member 40 12-01-31
Chun Lai Xia BRD
 Director/Board Member 50 16-04-30
Ying Chen
47 -
Jing Zhang BRD
 Director/Board Member 35 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 285,456,270 164,213,617 ( 57.53 %) 0 57.53 %

Shareholders

NameEquities%Valuation
Gfund Management Co., Ltd.
0.2990 %
853,600 0.2990 % 1 M ¥
CITIC-Prudential Fund Management Co., Ltd.
0.0432 %
123,300 0.0432 % 154 563 ¥
China Asset Management Co., Ltd.
0.0281 %
80,200 0.0281 % 100 535 ¥
Bosera Asset Management Co., Ltd.
0.0166 %
47,400 0.0166 % 59 418 ¥
China Southern Asset Management Co., Ltd.
0.0106 %
30,400 0.0106 % 38 108 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.009213 %
26,300 0.009213 % 32 968 ¥
Broad Fund Management Co. Ltd.
0.006621 %
18,900 0.006621 % 23 692 ¥
Dongxing Asset Management Co. Ltd.
0.001646 %
4,700 0.001646 % 5 892 ¥

Company contact information

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Bio-Health Industrial Park 9, Jianjing 1st Road

225127, Yangzhou

+

http://www.lhpharma.com
address Jiangsu Lianhuan Pharmaceutical Co., Ltd.(600513)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD. Stock Jiangsu Lianhuan Pharmaceutical Co., Ltd.
-13.02% 384M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.43% 690B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.43% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.12% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.59% 323B
ABBVIE INC. Stock AbbVie Inc.
+4.89% 287B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.32% 235B
NOVARTIS AG Stock Novartis AG
+5.79% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.49% 195B
AMGEN INC. Stock Amgen Inc.
+4.26% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600513 Stock
  4. Company Jiangsu Lianhuan Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW